Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Leukemia 24Leukemia, Myeloid, Acute 13Lymphoma 12Congenital Abnormalities 11Lymphoma, Follicular 10Head and Neck Neoplasms 10Breast Neoplasms 9Squamous Cell Carcinoma of Head and Neck 8Leukemia, Lymphocytic, Chronic, B-Cell 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Mantle-Cell 7Lymphoma, B-Cell, Marginal Zone 7Lung Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Sarcoma 6Precancerous Conditions 6Neuroblastoma 6Multiple Myeloma 6Melanoma 6Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, Large B-Cell, Diffuse 6Leukemia, Myeloid, Chronic-Phase 6Kidney Neoplasms 6Hodgkin Disease 6Colonic Neoplasms 6Burkitt Lymphoma 6Lymphoma, T-Cell, Cutaneous 5Lymphoma, Non-Hodgkin 5Colorectal Neoplasms 5Wilms Tumor 4

Interventions

Carboplatin 23Paclitaxel 18Bevacizumab 16Radiotherapy 15Erlotinib Hydrochloride 13Cisplatin 9Gemcitabine 7Gefitinib 7Docetaxel 7Taxes 6Pemetrexed 6Cetuximab 4Etoposide 3Amplified Fragment Length Polymorphism Analysis 3pegfilgrastim 2Vinorelbine 2Topotecan 2Radiotherapy, Conformal 2Radiation 2Irinotecan 2Gene Expression Profiling 2Anterior Temporal Lobectomy 2vandetanib 1sargramostim 1romidepsin 1lentiviral minigene vaccine of COVID-19 coronavirus 1irofulven 1cositecan 1advexin 1Video-Assisted Surgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Adenocarcinoma, Bronchiolo-Alveolar × Polymerase Chain Reaction × Clear all
NCT00900172 2017-05-19

Study of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab, Carboplatin, and Paclitaxel

Eastern Cooperative Oncology Group

Completed
180 enrolled
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡